Hamilton Lane Incorporated (NASDAQ:HLNE) is Copeland Capital Management LLC's 2nd Largest Position

→ My top 100 stocks… (From DTI) (Ad)

Copeland Capital Management LLC decreased its position in shares of Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 2.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 951,462 shares of the company's stock after selling 25,699 shares during the period. Hamilton Lane comprises 2.2% of Copeland Capital Management LLC's portfolio, making the stock its 2nd biggest position. Copeland Capital Management LLC owned about 1.76% of Hamilton Lane worth $107,934,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of HLNE. New York State Common Retirement Fund increased its holdings in shares of Hamilton Lane by 0.7% in the third quarter. New York State Common Retirement Fund now owns 17,238 shares of the company's stock valued at $1,559,000 after purchasing an additional 128 shares in the last quarter. Ameritas Investment Partners Inc. increased its holdings in shares of Hamilton Lane by 5.0% in the second quarter. Ameritas Investment Partners Inc. now owns 3,020 shares of the company's stock valued at $242,000 after purchasing an additional 144 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its holdings in shares of Hamilton Lane by 11.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 1,609 shares of the company's stock valued at $146,000 after purchasing an additional 168 shares in the last quarter. FMR LLC increased its holdings in shares of Hamilton Lane by 44.6% in the second quarter. FMR LLC now owns 600 shares of the company's stock valued at $40,000 after purchasing an additional 185 shares in the last quarter. Finally, State of Wyoming increased its holdings in shares of Hamilton Lane by 21.0% in the fourth quarter. State of Wyoming now owns 1,171 shares of the company's stock valued at $75,000 after purchasing an additional 203 shares in the last quarter. Institutional investors and hedge funds own 97.40% of the company's stock.


Hamilton Lane Trading Up 1.7 %

Shares of NASDAQ HLNE traded up $1.89 during midday trading on Friday, reaching $112.76. 346,329 shares of the stock were exchanged, compared to its average volume of 334,349. The business has a 50-day simple moving average of $113.40 and a two-hundred day simple moving average of $102.81. The company has a market capitalization of $6.09 billion, a price-to-earnings ratio of 34.70 and a beta of 1.18. Hamilton Lane Incorporated has a 12 month low of $62.86 and a 12 month high of $121.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.58 and a quick ratio of 2.58.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.71 earnings per share for the quarter, missing analysts' consensus estimates of $0.88 by ($0.17). The firm had revenue of $125.26 million for the quarter, compared to the consensus estimate of $130.47 million. Hamilton Lane had a return on equity of 28.77% and a net margin of 25.22%. The company's revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.43 earnings per share. As a group, equities research analysts expect that Hamilton Lane Incorporated will post 3.55 EPS for the current year.

Hamilton Lane Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 4th. Investors of record on Friday, March 15th will be given a $0.445 dividend. The ex-dividend date of this dividend is Thursday, March 14th. This represents a $1.78 annualized dividend and a yield of 1.58%. Hamilton Lane's dividend payout ratio is currently 54.77%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on HLNE shares. Morgan Stanley raised their price objective on shares of Hamilton Lane from $102.00 to $126.00 and gave the company an "equal weight" rating in a research note on Wednesday, January 24th. Wells Fargo & Company raised their price objective on shares of Hamilton Lane from $106.00 to $111.00 and gave the company an "equal weight" rating in a research note on Wednesday, February 7th. Finally, Oppenheimer cut shares of Hamilton Lane from an "outperform" rating to a "market perform" rating in a research note on Thursday, January 11th. Five analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $102.33.

Check Out Our Latest Research Report on HLNE

Insider Activity at Hamilton Lane

In related news, major shareholder Oakville Number 2 Trust sold 55,000 shares of the business's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $108.00, for a total value of $5,940,000.00. Following the sale, the insider now directly owns 480,015 shares of the company's stock, valued at approximately $51,841,620. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 26.82% of the stock is currently owned by insiders.

Hamilton Lane Company Profile

(Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Featured Stories

Institutional Ownership by Quarter for Hamilton Lane (NASDAQ:HLNE)

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in Hamilton Lane right now?

Before you consider Hamilton Lane, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.

While Hamilton Lane currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: